Medicine access options

Kisqali (ribociclib)
Breast Cancer

€3,016.39
Keytruda (pembrolizumab)
Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

€4,225.50
Kevzara (sarilumab)
Rheumatoid Arthritis

€1,749.49
Imfinzi (durvalumab)
Urothelial Carcinoma, Lung Cancer

€1,052.33
Ibrance (palbociclib)
Breast Cancer

€3,157.65
Fycompa (perampanel)
Epilepsy

€132.37
Empliciti (elotuzumab)
Multiple Myeloma

€1,354.60
Descovy (emtricitabine/tenofovir alafenamide)
HIV/AIDS

€564.54
Darzalex (daratumumab)
Multiple Myeloma

€804.45
Cotellic (cobimetinib)
Skin Cancer

€6,355.34
Cometriq (cabozantinib)
Thyroid Cancer

€6,222.09
Calcort (deflazacort)
Duchenne Muscular Dystrophy

€27.20